Maria D. Nieta-La
Ciudad Real, CM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA Nephropathy.
Journal: Kidney international reports
Published: April 06, 2023
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy.
Journal: Kidney360
Published: December 02, 2022
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy.
Journal: Clinical kidney journal
Published: February 01, 2022
How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR.
Journal: Journal of clinical medicine
Published: May 03, 2021
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: January 27, 2021
Validation of a Histologic Scoring Index for C3 Glomerulopathy.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: April 24, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: December 13, 2019
Erratum to Spanish Clinical Guidelines on Vascular Access for Haemodialysis.
Journal: Nefrologia
Published: July 16, 2019
IgA Nephropathy in Elderly Patients.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: November 11, 2018
Erratum to «Spanish Clinical Guidelines on Vascular Access for Haemodialysis».
Journal: Nefrologia
Published: May 24, 2018
Spanish Clinical Guidelines on Vascular Access for Haemodialysis.
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
Published: May 10, 2017
Acute tubulointerstitial nephritis in an HLA-B27-positive patient with axial spondyloarthritis being treated with adalimumab.
Journal: Reumatologia clinica
Published: December 09, 2016
Last Updated: 09/26/2026